The Effect of Mavacamten Treatment on Proteomic Cardiovascular Risk Score in Patients with Obstructive Hypertrophic Cardiomyopathy in the EXPLORER-HCM Study

Camzyos (mavacamten) - BMS

https://cattendee.abstractsonline.com/meeting/21541/presentation/4820

Zhaoqing Wang, Chun Wu, Victoria Florea, yu chen barrett, Bristol Myers Squibb, Princeton, NJ; Carolyn Ho, Brigham & Women's Hosp, Boston, MA; iacopo olivotto, Meyer Children’s Hosp, IRCCS, Florence, Italy

Sep 5, 2026